Pharma Co. Verrica Fails To Shed Investor Suit Over FDA OK

By Katryna Perera · September 5, 2024, 6:29 PM EDT

A Pennsylvania federal judge has partially denied Verrica Phamaceuticals Inc.'s second request to throw out a proposed class action filed by investors who claim the company defrauded them by hiding obstacles...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Case Information

Case Title

GORLAMARI v. VERRICA PHARMACEUTICALS, INC. et al

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Securities/Commodities

Date Filed

June 06, 2022

Recent Articles By Katryna

December 05, 2024
FINRA Fines Firm $900K Over SPAC Underwriting Fee Issues
November 04, 2024
Late New Evidence Can't Revive Investor Suit, Judge Says
October 31, 2024
Masimo Sues Ex-CEO Over 'Unprecedented' $450M Demand
October 28, 2024
SEC Sues To Enforce Subpoena On Telehealth Co.
September 27, 2024
Pharma Co. Amarin Beats Class Action Over Patent Issues
September 26, 2024
Healthcare REIT Defeats Investor Suit For Good
September 23, 2024
Mallinckrodt Brass Can't Avoid Investor Suit Over 2nd Ch. 11
September 23, 2024
SEC Scores $12M Judgment In Unregistered Dealer Case
August 21, 2024
Health Co. Investors Fight To Keep Suit Over Migrant Deal
August 06, 2024
Pharma Co. Founder Beats Suit Over Short-Swing Trading